SB-300, Jaguar's Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines

Results of Initial Study Show that Jaguar's Equine Product Candidate for Treatment of Gastric Ulcers May Offer Horse Owners an Additional Advantage in the Competition Horse World, where Requirements Exist for Animals to Compete Free from the Effect of Any Drugs

Sign up for our free eNews letter. We do not share our list and we send one per week. Select any of the topics below.

Sunday

June 24, 2018

Monday

June 25, 2018

Tuesday

June 26, 2018

Wednesday

June 27, 2018

Thursday

June 28, 2018

Friday

June 29, 2018

Saturday

June 30, 2018

Issue 115 ad